LIST OF TABLES
TABLE 1 PRIMARY INTERVIEWS 19
TABLE 2 LIST OF ASSUMPTIONS 23
TABLE 3 GLOBAL PEGYLATED DRUGS MARKET, BY MOLECULE 2016-2025 (USD MILLION) 32
TABLE 4 PROTEIN: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 33
TABLE 5 FAB' FRAGMENT: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 33
TABLE 6 ENZYME: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 34
TABLE 7 APTAMER: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 34
TABLE 8 GLOBAL PEGYLATED DRUGS MARKET, BY INDICATION 2016-2025 (USD MILLION) 36
TABLE 9 CANCER: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 37
TABLE 10 GOUT: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 37
TABLE 11 HEMOPHILIA: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 38
TABLE 12 HEPATITIS: MARKET ESTIMATES & FORECAST, BY REGION, 2016-2025 (USD MILLION) 38
TABLE 13 GLOBAL PEGYLATED DRUGS MARKET, BY REGION, 2016-2025 (USD MILLION) 40
TABLE 14 AMERICAS: PEGYLATED DRUGS MARKET, BY REGION, 2016-2025 (USD MILLION) 41
TABLE 15 AMERICAS: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 42
TABLE 16 AMERICAS: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 42
TABLE 17 NORTH AMERICA: PEGYLATED DRUGS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 43
TABLE 18 NORTH AMERICA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 43
TABLE 19 NORTH AMERICA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 43
TABLE 20 US: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 44
TABLE 21 US: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 44
TABLE 22 CANADA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 44
TABLE 23 CANADA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 45
TABLE 24 LATIN AMERICA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 45
TABLE 25 LATIN AMERICA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 45
TABLE 26 EUROPE: PEGYLATED DRUGS MARKET, BY REGION, 2016-2025 (USD MILLION) 46
TABLE 27 EUROPE: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 47
TABLE 28 EUROPE: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 47
TABLE 29 WESTERN EUROPE: PEGYLATED DRUGS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 48
TABLE 30 WESTERN EUROPE: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 48
TABLE 31 WESTERN EUROPE: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 48
TABLE 32 GERMANY: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 49
TABLE 33 GERMANY: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 49
TABLE 34 FRANCE: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 50
TABLE 35 FRANCE: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 50
TABLE 36 UK: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 51
TABLE 37 UK: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 51
TABLE 38 ITALY: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 52
TABLE 39 ITALY: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 52
TABLE 40 SPAIN: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 53
TABLE 41 SPAIN: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 53
TABLE 42 REST OF WESTERN EUROPE: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 54
TABLE 43 REST OF WESTERN EUROPE: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 54
TABLE 44 EASTERN EUROPE: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 55
TABLE 45 EASTERN EUROPE: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 55
TABLE 46 ASIA-PACIFIC: PEGYLATED DRUGS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 56
TABLE 47 ASIA-PACIFIC: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 57
TABLE 48 ASIA-PACIFIC: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 57
TABLE 49 JAPAN: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 58
TABLE 50 JAPAN: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 58
TABLE 51 CHINA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 59
TABLE 52 CHINA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 59
TABLE 53 INDIA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 60
TABLE 54 INDIA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 60
TABLE 55 AUSTRALIA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 61
TABLE 56 AUSTRALIA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 61
TABLE 57 SOUTH KOREA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 62
TABLE 58 SOUTH KOREA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 62
TABLE 59 REST OF ASIA-PACIFIC: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 63
TABLE 60 REST OF ASIA-PACIFIC: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 63
TABLE 61 MIDDLE EAST & AFRICA: PEGYLATED DRUGS MARKET, BY REGION, 2016-2025 (USD MILLION) 64
TABLE 62 MIDDLE EAST & AFRICA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 65
TABLE 63 MIDDLE EAST & AFRICA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 65
TABLE 64 MIDDLE EAST: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 66
TABLE 65 MIDDLE EAST: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 66
TABLE 66 AFRICA: PEGYLATED DRUGS MARKET, BY MOLECULE, 2016-2025 (USD MILLION) 67
TABLE 67 AFRICA: PEGYLATED DRUGS MARKET, BY INDICATION, 2016-2025 (USD MILLION) 67
TABLE 68 MAJOR PEGYLATED DRUGS 70
TABLE 69 PRODUCTS/SERVICES OFFERED 72
TABLE 70 KEY DEVELOPMENTS 72
TABLE 71 PRODUCTS PRODUCTS/SERVICES OFFERED 75
TABLE 72 PRODUCTS/SERVICES OFFERED 78
TABLE 73 KEY DEVELOPMENTS 78
TABLE 74 PRODUCTS/SERVICES OFFERED 81
TABLE 75 KEY DEVELOPMENTS 81
TABLE 76 PRODUCTS/SERVICES OFFERED 84
TABLE 77 KEY DEVELOPMENTS 84
TABLE 78 PRODUCTS/SERVICES OFFERED 87
TABLE 79 PRODUCTS/SERVICES OFFERED 90
TABLE 80 PRODUCTS/SERVICES OFFERED 93
TABLE 81 KEY DEVELOPMENTS 93
TABLE 82 PRODUCTS/SERVICES OFFERED 96
TABLE 83 KEY DEVELOPMENTS 96
TABLE 84 PRODUCTS/SERVICES OFFERED 99
TABLE 85 KEY DEVELOPMENTS 99
LIST OF FIGURE
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 13
FIGURE 2 GLOBAL PEGYLATED DRUGS MARKET ANALYSIS, BY MOLECULE 14
FIGURE 3 GLOBAL PEGYLATED DRUGS MARKET ANALYSIS, BY INDICATION 15
FIGURE 4 GLOBAL PEGYLATED DRUGS MARKET: STRUCTURE 17
FIGURE 5 RESEARCH PROCESS 18
FIGURE 6 TOP-DOWN & BOTTOM-UP APPROACHES 21
FIGURE 7 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PEGYLATED DRUGS MARKET 24
FIGURE 8 SUPPLY/VALUE CHAIN: GLOBAL PEGYLATED DRUGS MARKET 27
FIGURE 10 GLOBAL PEGYLATED DRUGS MARKET, BY MOLECULE, 2018 (% SHARE) 31
FIGURE 11 GLOBAL PEGYLATED DRUGS MARKET, BY MOLECULE, 2018 TO 2025 (USD MILLION) 32
FIGURE 12 GLOBAL PEGYLATED DRUGS MARKET, BY INDICATION, 2018 (% SHARE) 35
FIGURE 13 GLOBAL PEGYLATED DRUGS MARKET, BY INDICATION, 2018 TO 2025 (USD MILLION) 36
FIGURE 14 GLOBAL PEGYLATED DRUGS MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 39
FIGURE 15 GLOBAL PEGYLATED DRUGS MARKET, BY REGION, 2018 (% SHARE) 40
FIGURE 16 AMERICAS: PEGYLATED DRUGS MARKET SHARE, BY REGION, 2018 (% SHARE) 41
FIGURE 17 EUROPE: PEGYLATED DRUGS MARKET SHARE, BY REGION, 2018 (% SHARE) 46
FIGURE 18 ASIA-PACIFIC: PEGYLATED DRUGS MARKET SHARE, BY COUNTRY, 2018 (% SHARE) 56
FIGURE 19 MIDDLE EAST & AFRICA: PEGYLATED DRUGS MARKET SHARE, BY REGION, 2018 (% SHARE) 64
FIGURE 20 GLOBAL PEGYLATED DRUGS MARKET, SHARE ANALYSIS, 2018 (% SHARE) 68
FIGURE 21 FINANCIAL OVERVIEW SNAPSHOT 71
FIGURE 22 SWOT ANALYSIS 73
FIGURE 23 FINANCIAL OVERVIEW SNAPSHOT 74
FIGURE 24 SWOT ANALYSIS 75
FIGURE 25 FINANCIAL OVERVIEW SNAPSHOT 77
FIGURE 26 SWOT ANALYSIS 79
FIGURE 27 FINANCIAL OVERVIEW SNAPSHOT 80
FIGURE 28 SWOT ANALYSIS 82
FIGURE 29 FINANCIAL OVERVIEW SNAPSHOT 83
FIGURE 30 SWOT ANALYSIS 85
FIGURE 31 FINANCIAL OVERVIEW SNAPSHOT 86
FIGURE 32 SWOT ANALYSIS 87
FIGURE 33 FINANCIAL OVERVIEW SNAPSHOT 89
FIGURE 34 SWOT ANALYSIS 90
FIGURE 35 FINANCIAL OVERVIEW SNAPSHOT 92
FIGURE 36 SWOT ANALYSIS 94
FIGURE 37 FINANCIAL OVERVIEW SNAPSHOT 95
FIGURE 38 SWOT ANALYSIS 96
FIGURE 39 FINANCIAL OVERVIEW SNAPSHOT 98
FIGURE 40 SWOT ANALYSIS 99
